PAS
Point72 Asia (Singapore) Portfolio holdings
AUM
$563M
1-Year Return
23.62%
This Quarter Return
+10.68%
1 Year Return
+23.62%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$563M
AUM Growth
+$182M
(+48%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
25.13%
Top 10 Holdings %
Top 10 Hldgs %
22.34%
Holding
1,336
New
504
Increased
174
Reduced
170
Closed
483
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$18.7M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$13.4M |
| 3 |
Cheniere Energy
LNG
|
+$13.1M |
| 4 |
Advanced Micro Devices
AMD
|
+$12.9M |
| 5 |
HES
Hess
HES
|
+$12.3M |
Top Sells
| 1 |
Credo Technology Group
CRDO
|
+$25M |
| 2 |
Blackrock
BLK
|
+$12M |
| 3 |
Tapestry
TPR
|
+$8.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$8.32M |
| 5 |
Vertiv
VRT
|
+$7.52M |
Sector Composition
| 1 | Technology | 15.98% |
| 2 | Financials | 13.72% |
| 3 | Industrials | 13.21% |
| 4 | Communication Services | 11.73% |
| 5 | Healthcare | 11.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Avanos Medical
AVNS
$570M
| $62.7K | 0.01% |
5,120
+2,486
| +94% | +$30.4K |
|
552
Pilgrim's Pride
PPC
$10.5B
| $62.3K | 0.01% |
+1,385
| New | +$62.3K |
|
553
C4 Therapeutics
CCCC
$190M
| $62.1K | 0.01% |
43,447
+43,446
| +4,344,600% | +$62.1K |
|
554
Omega Flex
OFLX
$344M
| $62K | 0.01% |
1,915
+478
| +33% | +$15.5K |
|
555
H.B. Fuller
FUL
$3.39B
| $61.5K | 0.01% |
+1,023
| New | +$61.5K |
|
556
Definitive Healthcare
DH
$424M
| $61.3K | 0.01% |
15,723
+2,707
| +21% | +$10.6K |
|
|
CLDT
557
Chatham Lodging
CLDT
$353M
| $61.3K | 0.01% |
8,796
-28,881
| -77% | -$201K |
|
558
Aemetis
AMTX
$134M
| $61.1K | 0.01% |
+24,648
| New | +$61.1K |
|
559
MacroGenics
MGNX
$104M
| $60.8K | 0.01% |
+50,211
| New | +$60.8K |
|
560
FS KKR Capital
FSK
$4.97B
| $60.4K | 0.01% |
+2,910
| New | +$60.4K |
|
561
First Financial Bancorp
FFBC
$2.47B
| $60.4K | 0.01% |
2,488
-2,204
| -47% | -$53.5K |
|
562
The RealReal
REAL
$1.08B
| $59.7K | 0.01% |
+12,464
| New | +$59.7K |
|
563
Vicor
VICR
$2.27B
| $59.6K | 0.01% |
1,315
-2,976
| -69% | -$135K |
|
564
Performance Food Group
PFGC
$16.5B
| $59.2K | 0.01% |
677
-914
| -57% | -$79.9K |
|
565
Advantage Solutions
ADV
$613M
| $58.6K | 0.01% |
+44,399
| New | +$58.6K |
|
566
Taysha Gene Therapies
TSHA
$881M
| $58.3K | 0.01% |
+25,252
| New | +$58.3K |
|
567
Scansource
SCSC
$968M
| $58.3K | 0.01% |
1,394
+890
| +177% | +$37.2K |
|
568
EQT Corp
EQT
$31.8B
| $58.3K | 0.01% |
+999
| New | +$58.3K |
|
569
PBF Energy
PBF
$3.31B
| $58.2K | 0.01% |
+2,688
| New | +$58.2K |
|
|
UCB
570
United Community Banks, Inc.
UCB
$3.95B
| $56.9K | 0.01% |
1,910
-1,757
| -48% | -$52.3K |
|
|
ALX
571
Alexander's
ALX
$1.25B
| $56.8K | 0.01% |
+252
| New | +$56.8K |
|
572
MiMedx Group
MDXG
$1.03B
| $56.4K | 0.01% |
+9,229
| New | +$56.4K |
|
573
Leslie's
LESL
$62.2M
| $56.3K | 0.01% |
134,163
+79,935
| +147% | +$33.6K |
|
574
Pliant Therapeutics
PLRX
$102M
| $55.7K | 0.01% |
+48,007
| New | +$55.7K |
|
575
Y-mAbs Therapeutics
YMAB
$390M
| $54.9K | 0.01% |
12,171
-18,917
| -61% | -$85.3K |
|